The Elizabeth Holmes Trial: Former Schering-Plough Scientist Cites Theranos Founder’s ‘Cagey’ Behavior

The Elizabeth Holmes Trial: Former Schering-Plough Scientist Cites Theranos Founder’s ‘Cagey’ Behavior



For the second time since the trial of Elizabeth Holmes began, the jury heard testimony Tuesday that Theranos Inc. altered a document to show investors that its technology had been validated by a major pharmaceutical company.

Constance Cullen, an immunology expert who helped lead test development at pharmaceutical firm Schering-Plough Corp. , testified that she had been unimpressed with Theranos and found Ms. Holmes “cagey” during her process of evaluating the startup’s technology for a possible partnership. Despite that, prosecutors say, Theranos put Schering-Plough’s logo on a document it later gave to a prospective business partner and investor, purporting that the pharmaceutical company had checked out and validated its blood-testing devices.



Source link

Share:

Share on facebook
Facebook
Share on twitter
Twitter
Share on pinterest
Pinterest
Share on linkedin
LinkedIn
Rachel Meadows

Rachel Meadows

Trending topics news writer who enjoys cooking, walking her dog and travel.

Related Posts

Enter our vacation Giveaway to

Las Vegas!

Everyone wins a prize!